The Current Ratio as of December 2025 (TTM) for Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) is 1.76

According to Vcanbio Cell & Gene Engineering Corp., Ltd’s latest financial reports and current stock price. The company's current Current Ratio is 1.76. This represents a change of 3.13% compared to the average of 1.71 of the last 4 quarters.

Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) Historical Current Ratio (quarterly & annually)

How has 600645.SS Current Ratio performed in the past?

The mean historical Current Ratio of Vcanbio Cell & Gene Engineering Corp., Ltd over the last ten years is 1.24. The current 1.76 Current Ratio has changed 14.08% with respect to the historical average. Over the past ten years (40 quarters), 600645.SS's Current Ratio was at its highest in in the September 2025 quarter at 1.76. The Current Ratio was at its lowest in in the December 2017 quarter at 0.58.

Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Vcanbio Cell & Gene Engineering Corp., Ltd Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) Average Current Ratio

How has 600645.SS Current Ratio performed in the past?

The current Current Ratio of Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) Current Ratio vs. Peers

How is 600645.SS’s Current Ratio compared to its peers?

Vcanbio Cell & Gene Engineering Corp., Ltd’s Current Ratio is less than Jinyu Bio-technology Co., Ltd. (3.44), greater than Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (0.98), less than Zhejiang Jolly Pharmaceutical Co.,LTD (1.86), less than Hualan Biological Bacterin Inc. (3.26), greater than Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (1.34), less than Shanghai Haohai Biological Technology Co., Ltd. (3.77), less than China Resources Boya Bio-pharmaceutical Group Co., Ltd. (5.57), less than Chengdu Easton Biopharmaceuticals Co., Ltd. (3.50), greater than Chengdu Olymvax Biopharmaceuticals Inc. (1.52), less than Chengdu Kanghua Biological Products Co., Ltd. (5.85),

Build a custom stock screener for Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vcanbio Cell & Gene Engineering Corp., Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vcanbio Cell & Gene Engineering Corp., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.